Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma (TOPIAC)
Primary Purpose
Hemodynamic Instability
Status
Withdrawn
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
Tetracaine 0.5%
Lidocaine hydrochloride ophthalmic gel 3.5%
Sponsored by
About this trial
This is an interventional prevention trial for Hemodynamic Instability
Eligibility Criteria
Inclusion Criteria:
- Children with Retinoblastoma diagnosis scheduled for Intra-arterial chemotherapy under general anesthesia
Exclusion Criteria:
- any candidate with history of allergy to anesthetics or preservatives used in local anesthetics any candidate that has a history of allergic dermatitis any candidate that has an open wound in and around the eye to be treated
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Treatment session 1a
Arm Description
Topical ophthalmic anesthesia to participants (#) on each session (letter) of intra-arterial chemotherapy. where #1 is the participant identifier and letter-a is the start session with study protocol (most candidates will receive more than 4 sessions in a 6 month period)
Outcomes
Primary Outcome Measures
Decrease in systolic Blood Pressure
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Drop in end-tidal C02
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Decrease in lung compliance
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Decrease in oxygen saturation
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Cardiac arrythmia
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Secondary Outcome Measures
Recovery from Trigeminal-cardiac event
Investigator will communicate when the event is over or rescue drugs given.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02955524
Brief Title
Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma
Acronym
TOPIAC
Official Title
Topical Anesthesia to Decrease the Trigeminal-Cardiac Reflex During Intra-arterial Injection of Chemotherapy for Retinoblastoma in Children.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2018
Overall Recruitment Status
Withdrawn
Why Stopped
I discontinued this study because I transferred to another institution.
Study Start Date
March 2018 (Anticipated)
Primary Completion Date
June 2020 (Anticipated)
Study Completion Date
December 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Miami
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The objective of this study is to use local topical anesthesia to numb the sensory input, captured by branches of the Trigeminal nerve found on the skin in and around the eye, to decrease a hemodynamic reflex seen during placement of a catheter for intra-arterial chemotherapy (IAC) for eye tumors in children. This Trigeminal-cardiac reflex brings about hemodynamic instability during general anesthesia.
Normally, one could block this sensorial input with ophthalmic peribulbar placement of local anesthetics, but these eyes have malignant growth and invasive procedures may cause more harm. The investigators are aiming to numb the sensory branches of the trigeminal nerve non-invasively and observe for any decrease in these events.
Detailed Description
Retinoblastoma is a rare tumor of the eye and accounts for 6% of malignancies in children less than 5 years of age. Pediatric anesthesiologists have observed a series of hemodynamic instability following the insertion of a catheter into the cavernous segment of the internal carotid artery or during manipulation of a micro-catheter into the ophthalmic artery for intra-arterial chemotherapy (IAC) of retinoblastoma cases by neuroradiologists. This reaction has been recently published in case reports and observational studies as the treatment of these tumors have moved into the interventional imaging suites. This reaction closely resembles the "diving reflex" seen when a person is submerged in cold water; known as the trigeminal-cardiac reflex. It manifests as a sudden hemodynamic disturbance in arterial blood pressure, heart rate, arrhythmia and changes in pulmonary compliance.Rescue from a trigeminal-cardiac reflex entails increasing intravascular volume, administrating mild to resuscitative doses of epinephrine and ventilatory support.
Catheter manipulation around the ophthalmic artery can stimulate the afferent pathway of the trigeminal nerve, branches V1 and V2, originating around the eye to be treated.The ethmoidal nerve, from the nasal passage on the same side, is also stimulated. This in turn triggers a response by the vagus nerve with hemodynamic instability.
Method: Participants are placed under general endotracheal anesthesia for this scheduled procedure. One drop of ocular antiseptic (betadine 5%) will be placed in the eye to be treated followed by a drop of topical FDA approved local anesthetic, Tetracaine 0.5%, to the nasolacrimal duct ( inner corner of the eye) on the eye to be treated. This will numb the ethmoidal nerve in the nasal passage. This is followed by 1 ml of 3.5% Lidocaine gel to the surface of the eye. This gel is placed on the surface of the eye and skin around the eye to numb V1 and V2 fibers of the trigeminal nerve. The study will observe if there is any decrease in the intensity of the reflex or incidence of the reflex during placement of the micro-catheter.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemodynamic Instability
7. Study Design
Primary Purpose
Prevention
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Treatment session 1a
Arm Type
Experimental
Arm Description
Topical ophthalmic anesthesia to participants (#) on each session (letter) of intra-arterial chemotherapy.
where #1 is the participant identifier and letter-a is the start session with study protocol (most candidates will receive more than 4 sessions in a 6 month period)
Intervention Type
Drug
Intervention Name(s)
Tetracaine 0.5%
Intervention Description
One drop of 0.5% Proparacaine to nasolacrimal Duct to numb the ethmoidal nerve in the nasal passage on the side of the eye to be treated.
Intervention Type
Drug
Intervention Name(s)
Lidocaine hydrochloride ophthalmic gel 3.5%
Other Intervention Name(s)
Akten
Intervention Description
1ml of lidocaine gel is placed over the conjunctivae of the eye to be treated after the patient is under general anesthesia and before the procedure
Primary Outcome Measure Information:
Title
Decrease in systolic Blood Pressure
Description
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Time Frame
5 seconds
Title
Drop in end-tidal C02
Description
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Time Frame
5 seconds
Title
Decrease in lung compliance
Description
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Time Frame
5 seconds
Title
Decrease in oxygen saturation
Description
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Time Frame
5 seconds
Title
Cardiac arrythmia
Description
Interventionalist will communicate to the investigator of the catheter placement and our outcome measure will be recorded soon after.
Time Frame
5 seconds
Secondary Outcome Measure Information:
Title
Recovery from Trigeminal-cardiac event
Description
Investigator will communicate when the event is over or rescue drugs given.
Time Frame
2 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Children with Retinoblastoma diagnosis scheduled for Intra-arterial chemotherapy under general anesthesia
Exclusion Criteria:
any candidate with history of allergy to anesthetics or preservatives used in local anesthetics any candidate that has a history of allergic dermatitis any candidate that has an open wound in and around the eye to be treated
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jacqueline Tutiven, MD
Organizational Affiliation
Director Pediatric Anesthesia Fellowship/Assistant Professor
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Norman Halliday, MD
Organizational Affiliation
Chief, Pediatric Anesthesiology
Official's Role
Study Chair
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
27748655
Citation
Scharoun JH, Han JH, Gobin YP. Anesthesia for Ophthalmic Artery Chemosurgery. Anesthesiology. 2017 Jan;126(1):165-172. doi: 10.1097/ALN.0000000000001381. No abstract available.
Results Reference
result
PubMed Identifier
22793160
Citation
Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS, Chitale R, Rosenwasser R, Bianciotto CG, Shields C. Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr. 2012 Sep;10(3):175-81. doi: 10.3171/2012.5.PEDS1277. Epub 2012 Jul 13.
Results Reference
result
Learn more about this trial
Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma
We'll reach out to this number within 24 hrs